CABA — CABALETTA BIO INC

Ownership history in Point72 (DIFC) Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in CABALETTA BIO INC (CABA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q1)
Avg. % of fund
0.01%
First filed
2024 Q1
Last filed
2025 Q2
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 2,432 -9,323 -79.3% 0.00% $4K $1.52
2024 Q4 ADDED 11,755 +4,768 +68.2% 0.00% $27K $2.27
2024 Q3 REDUCED 6,987 -26,986 -79.4% 0.00% $33K $4.72
2024 Q1 INITIATED 33,973 — — 0.02% $580K —
% of Fund (quarterly)    CABA price (monthly, adj. close)

Other funds also holding CABA

As of 2025 Q4 — sorted by position size

SUPERSTRING CAPITAL MANAGEMENT LP 2.64% Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.62% Cormorant Asset Management, LP 3Y 7Y 0.45% Stonepine Capital Management, LLC 3Y 7Y 0.27% Opaleye Management Inc. 3Y 7Y 0.26% Almitas Capital LLC 3Y 7Y 0.19% Ikarian Capital, LLC 3Y 0.15% Burkehill Global Management, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.06% 683 Capital Management, LLC 3Y 7Y 0.04%
← Back to Point72 (DIFC) Ltd Holdings